Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity

Using the Protozoan Paramecium caudatum as a Vehicle for Food-borne Infections in Zebrafish Larvae

(2019) Erika Flores et al.   Jove-Journal of Visualized Experiments

The HCMV protein UL148A Downregulates the Activating NK Cell Ligand MICA to Avoid NK Cell Attack

(2018) Liat Dassa et al.   JOURNAL OF VIROLOGY

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors

(2018) Daniel Y. Wang et al.   JAMA Oncology

Targeting PVR (CD155) and its receptors in anti-tumor therapy

(2018) Paola Kučan Brlić et al.   Cellular & Molecular Immunology

Human anti‐NKp46 antibody for studies of NKp46‐dependent NK cell function and its applications for type 1 diabetes and cancer research

(2018) Orit Berhani et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Role of Mechanotransduction and Tension in T Cell Function

(2018) Jérémie Rossy et al.   Frontiers in Immunology

Nectin-3 is a new biomarker that mediates the upregulation of MMP2 and MMP9 in ovarian cancer cells

(2018) Feixue Xu et al.   BIOMEDICINE & PHARMACOTHERAPY

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

(2016) M. M-Rabet et al.   ANNALS OF ONCOLOGY

Nectin spot: a novel type of nectin-mediated cell adhesion apparatus

(2016) K. Mizutani et al.   BIOCHEMICAL JOURNAL

Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models

(2016) P. M. Challita-Eid et al.   CANCER RESEARCH

Identification of CD112R as a novel checkpoint for human T cells

(2016) Yuwen Zhu et al.   JOURNAL OF EXPERIMENTAL MEDICINE

PILRα binds an unknown receptor expressed primarily on CD56bright and decidual-NK cells and activates NK cell functions

(2016) Yael Ophir et al.   Oncotarget

Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA∗008 to Escape Elimination by NK Cells

(2015) Einat Seidel et al.   Cell Reports

DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information

(2014) I Amelio et al.   Cell Death & Disease

BioProfiling.de: analytical web portal for high-throughput cell biology

(2011) A. V. Antonov   NUCLEIC ACIDS RESEARCH

The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity

(2009) N. Stanietsky et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells

(2008) Xin Yu et al.   NATURE IMMUNOLOGY